Contract Research Organizations Market By Service Type (Drug Discovery, Preclinical Studies, Phase 1 and Others), By Therapeutic (Oncology, Infectious diseases, Cardiovascular diseases, Metabolic Disease And Others) And By Regions - Global Forecast To 2021

Starting Price : $ 4000.00 $ 2680.00 | Pages : 250 | Published : July 2018 | SKU CODE : o&s003 | Format :

Request Sample

Contract Research Organizations Market Definition

Contract Research Organizations (CROs) offer end-to-end solutions in conducting clinical trials for pharmaceutical, biotechnology and medical device companies, collectively referred to as sponsors. The core services offered by CROs to biopharmaceutical companies include initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services.

Contract Research Organizations Market Size

The global contract research organizations market reached a value of nearly $44.4 billion in 2017, having grown at a compound annual growth rate (CAGR) of more than 9.9% since 2013.

Growth in the contract research organizations market in the historic period resulted from the rising cost of drug development, increasing patent expirations of drugs and growing biologics market. Factors that negatively affected growth in the historic period were clinical trial failures and stringent and differing government regulations.

Going forward, growing demand for outsourcing services in emerging countries and expanding scope of CRO solutions through technology will drive growth. Factors that could hinder the growth of this market in the future include data safety concerns and CRO scandals will affect market growth.

Contract Research Organizations Market Drivers

The Key drivers of the contract research organizations market include:

Increasing Patent Expirations Of Drugs - Various top selling block buster drugs have reached their patent expiry and this has forced pharmaceutical companies to invest more on drug development process to come up with new and more effective products. About 61 drugs lost their patent protection in 2016, and patents of 43 drugs expired in 2017. Pharmaceutical companies are facing strong competition from generic and biosimilar drug manufacturers, but they are focused on cost containment and shortening development timelines without compromising quality, thus the patent expiration of drugs is driving the CRO market. CROs are also likely to benefit from the growth of biosimilars as patents for biologics representing billions of dollars have expired or are set to expire soon.

Contract Research Organizations Market Restraints

The key restraints on the contract research organizations market include:

Stringent And Differing Government Regulations - Majority of the clinical trials and other research processes are outsourced to various countries simultaneously. These destination countries have different guidelines and regulatory processes related to drugs, filing and clinical trials, this can cause issues and act as a restraint on the market. The conduction of multi-location trials of a single drug in different procedures in different countries poses a challenge to pharmaceutical companies as they have to follow a completely different procedure in each country. This is observed as one of the major challenges for research outsourcing in different countries and therefore, a company prefers to restrict outsourcing to one destination country. This restricts the research outsourcing market on a global level. For instance; clinical trials, regulatory filings and approval of drugs in India and China have variations. India and China are the major research outsourcing destinations, compelling pharmaceutical companies to choose either of them for outsourcing research.

Contract Research Organizations Market Trends

Major trends influencing the contract research organizations market include:

Personalized Medicine/Genetic Testing Capabilities - CROs are focusing on investing in personalized medicine and gene testing capabilities to aid in the development of more targeted and effective medicines. This trend can be attributed to the biopharmaceutical pipeline shifting towards specialty therapeutics, where the utilization of personalized medicine is inherently greater it they can dramatically improve outcomes. For example, ICON established a partnership with Genomics England, which provides DNA-mapping services for patients focusing on cancer, rare and infectious diseases. With this partnership, ICON aims to better advise biopharmaceutical companies on how to capture genomic indicators to aid in the therapeutic development process.

Strategic Partnerships To Benefit CROs And Sponsors Alike - CROs are forming strategic partnerships with large biopharma companies to establish a strong CRO-sponsor relationship. Strategic partnerships help CROs by providing them with improved visibility, higher network utilization and expanded capabilities. On the other hand, strategic deals offer sponsors attractive pricing, expertise in disease areas and regulatory compliance, improved global reach and accelerated time to market. For instance, in 2015, Parexel International formed a strategic alliance with Optum, a business division of UnitedHealth Group. Other strategic partnerships between CROs and their sponsors include, Quintiles-Ascendancy Healthcare, CRS-Bayer, LabCorp-BMS and ICON-Pfizer.  According to a study from Parexel International, about 85% of biopharmaceutical executives viewed strategic partnerships as positively impacting CRO-sponsor relationships.

Contract Research Organizations Market Segmentation

The Contract Research Organizations market is segmented by service type, by therapeutic area and by geography.
By Service Type- The contract research organizations market is segmented by service type into
    • a) Preclinical Studies
    • b) Phase I
    • c) Phase II
    • d) Phase III
    • e) Phase IV
    • f) Drug Discovery
    • g) Others
Phase II had the highest growth rate of nearly 12.19% during the historic period.
By Therapeutic Area -
The contract research organizations market is segmented by therapeutic area into
    • a) Oncology
    • b) CNS Disorder
    • c) Cardiovascular Disease
    • d) Metabolic Disease
    • e) Infectious Disease
    • f) Other Therapeutic Area
By Geography - The contract research organizations market is segmented into
    • o North America
      • USA
    • o Western Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
North America is the largest market for contract research organizations, accounting for almost 42% of the global market. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, Asia-Pacific and Eastern Europe will be the fastest growing regions in this market.

Contract Research Organizations Competitive Landscape

Major Competitors are:
    • • IQVIA
    • • Laboratory Corporation of America Holdings
    • • ICON Plc
    • • PAREXEL
    • • PPD
Other Competitors Include:
    • • Pharmaceutical Product Development
    • • Syneos Health
    • • Charles River Laboratory
    • • Wuxi Pharmatech
    • • Medspace Holdings
    • • Envigo
    • • PSI CRO AG

  1. 1.Executive Summary
  2. 2.Contract Research Organizations Market Characteristics
  3. 3.Porter’s Five Forces Analysis
  4. 4.Global CRO Market Size And Growth
    • 4.1.Global CRO Market Historic Market Growth, Value
      • 4.1.1.Drivers Of The Market
      • 4.1.2.Restraints On The Market
    • 4.2.Global CRO Market Forecast Growth, Value
      • 4.2.1.Drivers Of The Market
      • 4.2.2.Restraints On The Market
  5. 5.Global CRO Market Segmentation
    • 5.1.Global CRO Market, Segmentation By Service Type
      • Drug discovery
      • Preclinical studies
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
      • Other Services
    • 5.2.Global CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 5.3.Global CRO Production, Segmentation By Therapeutic Area
      • Oncology
      • Infectious diseases
      • Central nervous system
      • Cardiovascular diseases
      • Metabolic Disease
      • Other Therapeutic Area
    • 5.4.Global CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 5.5.Global CRO Market, 2017, By Region
    • 5.6.Global CRO Market, 2013-2021, Historic And Forecast Growth Rate, By Region
    • 5.7.Global CRO Market, 2017, By Country
    • 5.8.Global CRO Market, 2013-2017, Historic And Forecast Growth Rate, By Country
  6. 6.Global CRO Market Comparison with Macro Economic Factors
    • 6.1.CRO Market Size, Percentage of GDP, By Country
    • 6.2.Per Capita Average CRO Expenditure, By Country
  7. 7.North America CRO Market Overview
    • 7.1.North America CRO Market Information
    • 7.2.North America CRO Production Historic Market Growth, Value
    • 7.3.North America CRO Production Forecast Growth, Value
    • 7.4.North America CRO Production, Segmentation By Service Type
    • 7.5.North America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 7.6.North America CRO Production, Segmentation By Therapeutic Area
    • 7.7.North America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 7.8.North America CRO Consumption Historic Market Growth, Value
    • 7.9.North America CRO Consumption Forecast Growth, Value
  8. 7.10.USA CRO Market Overview
    • 7.10.1.USA CRO Market Information
    • 7.10.2.USA CRO Production Historic Market Growth, Value
    • 7.10.3.USA CRO Production Forecast Growth, Value
    • 7.10.4.USA CRO Production, Segmentation By Service Type
    • 7.10.5.USA CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 7.10.6.USA CRO Production, Segmentation By Therapeutic Area
    • 7.10.7.USA CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 7.10.8.USA CRO Consumption Historic Market Growth, Value
    • 7.10.9.USA CRO Consumption Forecast Growth, Value
  9. 8.Asia-Pacific CRO Market Overview
    • 8.1.Asia-Pacific CRO Market Information
    • 8.2.Asia-Pacific CRO Production Historic Market Growth, Value
    • 8.3.Asia-Pacific CRO Production Market Forecast Growth, Value
    • 8.4.Asia-Pacific CRO Production, Segmentation By Service Type
    • 8.5.Asia-Pacific CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 8.6.Asia-Pacific CRO Production, Segmentation By Therapeutic Area
    • 8.7.Asia-Pacific CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 8.8.Asia-Pacific CRO Consumption Historic Market Growth, Value
    • 8.9.Asia-Pacific CRO Consumption Market Forecast Growth, Value
    • 8.10.China CRO Market Overview
      • 8.10.1.China CRO Market Information
      • 8.10.2.China CRO Production Historic Market Growth, Value
      • 8.10.3.China CRO Production Forecast Growth, Value
      • 8.10.4.China CRO Production, Segmentation By Service Type
      • 8.10.5.China CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 8.10.6.China CRO Production, Segmentation By Therapeutic Area
      • 8.10.7.China CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 8.10.8.China CRO Consumption Historic Market Growth, Value
      • 8.10.9.China CRO Consumption Forecast Growth, Value
    • 8.11.India CRO Market Overview
      • 8.11.1.India CRO Market Information
      • 8.11.2.India CRO Production Historic Market Growth, Value
      • 8.11.3.India CRO Production Forecast Growth, Value
      • 8.11.4.India CRO Production, Segmentation By Service Type
      • 8.11.5.India CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 8.11.6.India CRO Production, Segmentation By Therapeutic Area
      • 8.11.7.India CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 8.11.8.India CRO Consumption Historic Market Growth, Value
      • 8.11.9.India CRO Consumption Forecast Growth, Value
    • 8.12.Japan CRO Market Overview
      • 8.12.1.Japan CRO Market Information
      • 8.12.2.Japan CRO Production Historic Market Growth, Value
      • 8.12.3.Japan CRO Production Forecast Growth, Value
      • 8.12.4.Japan CRO Production, Segmentation By Service Type
      • 8.12.5.Japan CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 8.12.6.Japan CRO Production, Segmentation By Therapeutic Area
      • 8.12.7.Japan CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 8.12.8.Japan CRO Consumption Historic Market Growth, Value
      • 8.12.9.Japan CRO Consumption Forecast Growth, Value
    • 8.13.Australia CRO Market Information
      • 8.13.1.Australia CRO Production Historic Growth, Value
      • 8.13.2.Australia CRO Production Forecast Growth, Value
      • 8.13.3.Australia CRO Production, Segmentation By Service Type
      • 8.13.4.Australia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 8.13.5.Australia CRO Production, Segmentation By Therapeutic Area
      • 8.13.6.Australia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 8.13.7.Australia CRO Consumption Historic Growth, Value
      • 8.13.8.Australia CRO Consumption Forecast Growth, Value
  10. 9.Western Europe CRO Market Overview
    • 9.1.Western Europe CRO Market Information
    • 9.2.Western Europe CRO Production Historic Growth, Value
    • 9.3.Western Europe CRO Production Forecast Growth, Value
    • 9.4.Western Europe CRO Production, Segmentation By Service Type
    • 9.5.Western Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 9.6.Western Europe CRO Production, Segmentation By Therapeutic Area
    • 9.7.Western Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 9.8.Western Europe CRO Consumption Historic Growth, Value
    • 9.9.Western Europe CRO Consumption Forecast Growth, Value
    • 9.10.UK CRO Market Overview
      • 9.10.1.UK CRO Market Information
      • 9.10.2.UK CRO Production Historic Growth, Value
      • 9.10.3.UK CRO Production Forecast Growth, Value
      • 9.10.4.UK CRO Production, Segmentation By Service Type
      • 9.10.5.UK CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 9.10.6.UK CRO Production, Segmentation By Therapeutic Area
      • 9.10.7.UK CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 9.10.8.UK CRO Consumption Historic Growth, Value
      • 9.10.9.UK CRO Consumption Forecast Growth, Value
    • 9.11.Germany CRO Market Information
      • 9.11.1.Germany CRO Production Historic Market Growth, Value
      • 9.11.2.Germany CRO Production Forecast Growth, Value
      • 9.11.3.Germany CRO Production, Segmentation By Service Type
      • 9.11.4.Germany CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 9.11.5.Germany CRO Production, Segmentation By Therapeutic Area
      • 9.11.6.Germany CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 9.11.7.Germany CRO Consumption Historic Market Growth, Value
      • 9.11.8.Germany CRO Consumption Forecast Growth, Value
    • 9.12.France CRO Market Information
      • 9.12.1.France CRO Production Historic Market Growth, Value
      • 9.12.2.France CRO Production Forecast Growth, Value
      • 9.12.3.France CRO Production, Segmentation By Service Type
      • 9.12.4.France CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 9.12.5.France CRO Production, Segmentation By Therapeutic Area
      • 9.12.6.France CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 9.12.7.France CRO Consumption Historic Market Growth, Value
      • 9.12.8.France CRO Consumption Forecast Growth, Value
    • 9.13.Spain CRO Market Information
      • 9.13.1.Spain CRO Production Historic Market Growth, Value
      • 9.13.2.Spain CRO Production Forecast Growth, Value
      • 9.13.3.Spain CRO Production, Segmentation By Service Type
      • 9.13.4.Spain CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 9.13.5.Spain CRO Production, Segmentation By Therapeutic Area
      • 9.13.6.Spain CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 9.13.7.Spain CRO Consumption Historic Market Growth, Value
      • 9.13.8.Spain CRO Consumption Forecast Growth, Value
    • 9.14.Italy CRO Market Information
      • 9.14.1.Italy CRO Production Historic Market Growth, Value
      • 9.14.2.Italy CRO Production Forecast Growth, Value
      • 9.14.3.Italy CRO Production, Segmentation By Service Type
      • 9.14.4.Italy CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 9.14.5.Italy CRO Production, Segmentation By Therapeutic Area
      • 9.14.6.Italy CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 9.14.7.Italy CRO Consumption Historic Market Growth, Value
      • 9.14.8.Italy CRO Consumption Forecast Growth, Value
  11. 10.Eastern Europe CRO Market Overview
    • 10.1.Eastern Europe CRO Market Information
    • 10.2.Eastern Europe CRO Production Historic Market Growth, Value
    • 10.3.Eastern Europe Production Forecast Growth, Value
    • 10.4.Eastern Europe CRO Production, Segmentation By Service Type
    • 10.5.Eastern Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 10.6.Eastern Europe CRO Production, Segmentation By Therapeutic Area
    • 10.7.Eastern Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 10.8.Eastern Europe CRO Consumption Historic Market Growth, Value
    • 10.9.Eastern Europe Consumption Forecast Growth, Value
    • 10.10.Russia CRO Market Information
      • 10.10.1.Russia CRO Production Historic Growth, Value
      • 10.10.2.Russia CRO Production Forecast Growth, Value
      • 10.10.3.Russia CRO Production, Segmentation By Service Type
      • 10.10.4.Russia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 10.10.5.Russia CRO Production, Segmentation By Therapeutic Area
      • 10.10.6.Russia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 10.10.7.Russia CRO Consumption Historic Growth, Value
      • 10.10.8.Russia CRO Consumption Forecast Growth, Value
  12. 11.South America CRO Market Overview
    • 11.1.South America CRO Market Information
    • 11.2.South America CRO Production Historic Growth, Value
    • 11.3.South America CRO Production Forecast Growth, Value
    • 11.4.South America CRO Production, Segmentation By Service Type
    • 11.5.South America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 11.6.South America CRO Production, Segmentation By Therapeutic Area
    • 11.7.South America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 11.8.South America CRO Consumption Historic Growth, Value
    • 11.9.South America CRO Consumption Forecast Growth, Value
    • 11.10.Brazil CRO Market Information
      • 11.10.1.Brazil CRO Production Historic Growth, Value
      • 11.10.2.Brazil CRO Production Forecast Growth, Value
      • 11.10.3.Brazil CRO Production, Segmentation By Service Type
      • 11.10.4.Brazil CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
      • 11.10.5.Brazil CRO Production, Segmentation By Therapeutic Area
      • 11.10.6.Brazil CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
      • 11.10.7.Brazil CRO Consumption Historic Growth, Value
      • 11.10.8.Brazil CRO Consumption Forecast Growth, Value
  13. 12.Middle East CRO Market Overview
    • 12.1.Middle East CRO Market Information
    • 12.2.Middle East CRO Production Historic Growth, Value
    • 12.3.Middle East CRO Production Forecast Growth, Value
    • 12.4.Middle East CRO Production, Segmentation By Service Type
    • 12.5.Middle East CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 12.6.Middle East CRO Production, Segmentation By Therapeutic Area
    • 12.7.Middle East CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 12.8.Middle East CRO Consumption Historic Growth, Value
    • 12.9.Middle East CRO Consumption Forecast Growth, Value
  14. 13.Africa CRO Market Overview
    • 13.1.Africa CRO Market Information
    • 13.2.Africa CRO Production Historic Growth, Value
    • 13.3.Africa CRO Production Forecast Growth, Value
    • 13.4.Africa CRO Production, Segmentation By Service Type
    • 13.5.Africa CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
    • 13.6.Africa CRO Production, Segmentation By Therapeutic Area
    • 13.7.Africa CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
    • 13.8.Africa CRO Consumption Historic Growth, Value
    • 13.9.Africa CRO Consumption Forecast Growth, Value
  15. 14.Key M&A and Strategic Partnerships in The Global CRO Market
  16. 15.CRO Market Competitive Landscape
    • 15.1.Competitive Analysis Of Global CRO Market Players
      • 15.1.1.Key Players In Preclinical And Clinical Development
    • 15.2.Company Profiles
      • 15.2.1.IQVIA
      • 15.2.2.Laboratory Corporation Of America Holdings
      • 15.2.3.ICON Plc
      • 15.2.4.PAREXEL International Corporation
      • 15.2.5.Pharmaceutical Product Development (PPD), Inc.
  17. 16.Customer Information
  18. 17.Global CRO Market Segmentation By End-Users
    • 17.1.CRO Market Trends And Strategies
  19. 18.Appendix
    • 18.1.Market Data Sources
    • 18.2.Primary Research – Interview Transcripts
      • 18.2.1.Interview – 1
      • 18.2.2.Interview – 2
    • 18.3.Research Methodology
    • 18.4.Note on Currency Conversions
    • 18.5.Research Inquiries
    • 18.6.The Business Research Company
    • 18.7.Copyright and Disclaimer
Dental Tourism And Adoption Of New Technology In The Dental Services Industry
Global Contract Research Organizations market | Characteristics, Forecast Size, Trends
Global Veterinary Services market | Characteristics, Forecast Size, Trends
Teletherapy: A Solution To Diagnose And Treat Patients Online
DocOn: An App For Accessing Prescription Records Online
Micro Birthing To Simulate The Infants Immune System
Mathematical Modelling For The Treatment Of Brain Diseases
Medical And Diagnostic Laboratory Services Global Market Report 2019
View Report
Physicians And Other Health Practitioners Global Market Report 2019
View Report
Ambulance Services Global Market Report 2019
View Report
Residential Substance Abuse And Mental Health Facilities Market Global Briefing 2018
View Report
Home Health Care Providers Global Market Report 2018
View Report
Diagnostic Imaging Centers Global Market Report 2018
View Report
Home Health Care And Residential Nursing Care Services Global Market Report 2018
View Report
Retirement Communities Global Market Report 2018
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)